Enterprise Value

228.4M

Cash

58.55M

Avg Qtr Burn

-11.33M

Short % of Float

18.11%

Insider Ownership

0.96%

Institutional Own.

31.60%

Qtr Updated

03/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Defencath Details
Infectious disease, Catheter related blood stream infections

Approved

Quarterly sales